Press Releases

Press Releases

Date Title and Summary Additional Formats
Toggle Summary First HIFU patient treated at Allied Urological Services in New York City with the Ablatherm® Robotic HIFU device
Procedures Performed by Dr. Altan Ilkay
View HTML
Toggle Summary First Patients Treated With EDAP's Ablatherm® Robotic HIFU in New York
Procedures Performed at Gramercy Surgery Center by Dr. Ivan Grunberger, Assisted by Dr. Judd Boczko
View HTML
Toggle Summary First Prostate Ablation Treatments Performed Using EDAP's FDA Approved Ablatherm® Robotic HIFU at Sylvester Comprehensive Cancer Center, in Miami, Florida
LYON, France , Jan. 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the first prostate ablation treatments performed at Sylvester Comprehensive Cancer Center , Miami , using FDA approved Ablatherm Robotic HIFU.
View HTML
Toggle Summary From UroToday.com: Ablatherm® - HIFU: A New Perspective in 2007, the Year of the First Long Term Clinical Results on the Treatment of Localised Prostate Cancer
From UroToday.com: Ablatherm® - HIFU: A New Perspective in 2007, the Year of the First Long Term Clinical Results on the Treatment of Localised Prostate Cancer UroToday.com announced today the addition of Ablatherm® - HIFU: A New Perspective in 2007, the Year of the First Long Term Clinical Results
View HTML
Toggle Summary HIFU Resource Center Online at www.urotoday.com
HIFU Resource Center Online at www.urotoday.com EDAP and the Ablatherm-HIFU now have a HIFU section in the most popular urology web site in the world : http://www.urotoday.com . Urotoday.com is a scientific web site serving urologists visited by more than 50,000 urologists every month worldwide.
View HTML
Toggle Summary Houston Methodist Hospital, Houston, TX Acquires and Installs EDAP's Ablatherm® Robotic HIFU
LYON, France , April 25, 2016 (GLOBE NEWSWIRE) -- EDAP TMS SA (Nasdaq:EDAP), the global leader in therapeutic ultrasound, today announced the sale and installation of Ablatherm Robotic HIFU at Houston Methodist Hospital , Houston, Texas . The hospital is the first location in Texas to install
View HTML
Toggle Summary Largest Long-Term Study Confirms EDAP's Ablatherm® HIFU is Effective, Highly Reproducible Primary Treatment for Localized Prostate Cancer
-- 2,552 Patient, International, Multi-Center, 10-year Study Shows 83% of Patients Cancer Free --
View HTML
Toggle Summary Maple Leaf HIFU and EDAP Continue North American Success at Canadian Conference
Continued Interest from Leading Urologists; Growing Treatment Activity and Referrals
View HTML
Toggle Summary New Ablatherm®-HIFU Site Launched in the United Kingdom
First UK Fixed Revenue-Per-Procedure Service Available at Capio Springfield Hospital
View HTML
Toggle Summary News Article: Ultrasound Waves Being Used To Treat Prostate Cancer
The following article appeared September 27, 2006 in WRAL.com serving the Raleigh-Durham & Fayetteville, North Carolina areas. The story can be viewed at http://www.wral.com/health/9947426/detail.html. Ultrasound Waves Being Used To Treat Prostate Cancer
View HTML